Equity Components [Axis]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Treasury Stock, Common [Member]
Ownership [Axis]
Immix Biopharma Australia Pty Ltd. [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
June 2025 ATM Agreement [Member]
Statistical Measurement [Axis]
Minimum [Member]
Maximum [Member]
Citizens ATM Agreement [Member]
Securities Purchase Agreements [Member]
Warrant [Member]
PreFunded Warrant [Member]
Award Type [Axis]
Australian Tax Incentive [Member]
Class of Stock [Axis]
Prefunded Warrants [Member]
Antidilutive Securities [Axis]
Stock Options and Warrants Exercisable [Member]
Stock Options and Warrants Exercisable One [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value, Inputs, Level 1 [Member]
Cash and Cash Equivalents [Axis]
Money Market Funds [Member]
Fair Value, Inputs, Level 2 [Member]
Fair Value, Inputs, Level 3 [Member]
US Treasury Securities [Member]
Long-Lived Asset, Class [Axis]
Operating Equipment [Member]
Electronic Equipment [Member]
Office Equipment [Member]
Leasehold Improvements [Member]
Sale of Stock [Axis]
Underwritten Offering [Member]
Class of Warrant or Right [Axis]
2026 Underwriting Agreement [Member]
Marketing Service Agreement [Member]
Award Date [Axis]
July 25, 2023 [Member]
Marketing Services Agreement [Member]
Common Stock Warrants [Member]
Plan Name [Axis]
Nexcella 2022 Equity Incentive Plan [Member]
Restricted Stock [Member]
2016 Plan [Member]
2021 Plan [Member]
Amended and Restated 2021 Omnibus Equity Incentive Plan [Member]
Amended and Restated 2022 Omnibus Equity Incentive Plan [Member]
Title and Position [Axis]
Non-Employees [Member]
Management of the Company [Member]
Employees [Member]
Exercise Price Range [Axis]
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Range Six [Member]
Research and License Agreement [Member]
Research and Development Arrangement, Contract to Perform for Others, Type [Axis]
License Agreement Terms [Member]
License Agreement [Member]
Counterparty Name [Axis]
Phase II Studies [Member]
Phase III Studies [Member]
Licensed Product [Member]
Employment Agreement [Member]
Dr. Rachman [Member]
Management Sevices Agreement [Member]
Mr. Morris [Member]
Robinhood I I L P [Member]
Subsequent Event Type [Axis]
Subsequent Event [Member]
Cover [Abstract]
Document Type
Amendment Flag
Amendment Description
Document Registration Statement
Document Annual Report
Document Quarterly Report
Document Transition Report
Document Shell Company Report
Document Shell Company Event Date
Document Period Start Date
Document Period End Date
Document Fiscal Period Focus
Document Fiscal Year Focus
Current Fiscal Year End Date
Entity File Number
Entity Registrant Name
Entity Central Index Key
Entity Primary SIC Number
Entity Tax Identification Number
Entity Incorporation, State or Country Code
Entity Address, Address Line One
Entity Address, Address Line Two
Entity Address, Address Line Three
Entity Address, City or Town
Entity Address, State or Province
Entity Address, Country
Entity Address, Postal Zip Code
Country Region
City Area Code
Local Phone Number
Extension
Written Communications
Soliciting Material
Pre-commencement Tender Offer
Pre-commencement Issuer Tender Offer
Title of 12(b) Security
No Trading Symbol Flag
Trading Symbol
Security Exchange Name
Title of 12(g) Security
Security Reporting Obligation
Annual Information Form
Audited Annual Financial Statements
Entity Well-known Seasoned Issuer
Entity Voluntary Filers
Entity Current Reporting Status
Entity Interactive Data Current
Entity Filer Category
Entity Small Business
Entity Emerging Growth Company
Elected Not To Use the Extended Transition Period
Document Accounting Standard
Other Reporting Standard Item Number
Entity Shell Company
Entity Public Float
Entity Bankruptcy Proceedings, Reporting Current
Entity Common Stock, Shares Outstanding
Documents Incorporated by Reference [Text Block]
Statement of Financial Position [Abstract]
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Prepaid expenses and other current assets
Total current assets
Other assets
Deferred offering costs
Long-term investments
Right-of-use assets, net
Property and equipment, net
Total assets
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued expenses
Operating lease liability - current
Total current liabilities
Operating lease liability – long term
Total liabilities
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding
Common stock, $0.0001 par value; 200,000,000 shares authorized; 71,608,042 shares issued and 71,535,679 shares outstanding at June 30, 2026 and 53,023,466 shares issued and 52,951,103 shares outstanding at December 31, 2025
Additional paid-in capital
Accumulated other comprehensive income
Accumulated deficit
Treasury stock at cost, 72,363 shares as of June 30, 2026 and December 31, 2025
Total stockholders’ equity
Total liabilities and stockholders’ equity
Preferred stock, par value
Preferred stock, shares authorized
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value
Common stock, shares authorized
Common stock, shares issued
Common stock, shares outstanding
Treasury stock, shares
Income Statement [Abstract]
Operating expenses:
General and administrative expenses
Research and development
Total operating expenses
Loss from operations
Other income:
Interest income
Total other income, net
Loss before provision for income taxes
Provision for income taxes
Net loss
Other comprehensive income:
Unrealized (loss) gains on available-for-sale securities
Foreign currency translation
Total other comprehensive income
Comprehensive loss
Loss per common share - basic
Loss per common share - diluted
Weighted average shares outstanding - basic
Weighted average shares outstanding - diluted
Statement [Table]
Statement [Line Items]
Balance
Balance, shares
Treasury shares, balance
Shares issued for exercise of stock options
Shares issued for exercise of stock options, shares
Shares issued for cashless exercise of warrants
Shares issued for cashless exercise of warrants, shares
Shares issued for services
Shares issued for services, shares
Stock-based compensation
Net loss
Unrealized gain (loss) on available-for-sale securities
Foreign currency translation adjustment
Shares issued under ATM facility for cash proceeds, net of offering costs
Shares issued under ATM facility for cash proceeds, net of offering costs, shares
Shares issued under public offering for cash proceeds, net of offering costs
Shares issued under public offering for cash proceeds, net of offering costs, shares
Shares issued for cash exercise of warrants
Shares issued for cash exercise of warrants, shares
Shares issued for vested restricted stock awards
Shares issued for vested restricted stock awards
Balance
Balance, shares
Treasury shares, balance
Statement of Cash Flows [Abstract]
Operating Activities:
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation
Amortization of right of use asset
Loss on disposal of fixed assets
Realized gain on available-for-sale securities
Changes in operating assets and liabilities:
Tax receivable
Prepaid expenses and other current assets
Accounts payable and accrued expenses
Operating lease liability
Net cash used in operating activities
Investing Activities:
Purchase of property and equipment
Proceeds from the sale of investments
Purchase of investments
Net cash used in investing activities
Financing Activities:
Proceeds from sale of common stock under public offering, net of offering costs
Proceeds from sale of common stock under ATM facility, net of offering costs
Proceeds from exercise of stock warrants
Proceeds from exercise of stock options
Net cash provided by financing activities
Effect of foreign currency on cash
Net change in cash and cash equivalents
Cash and cash equivalents – beginning of period
Cash and cash equivalents – end of period
Supplemental Disclosures of Cash Flow Information:
Income taxes paid
Supplemental Disclosures of Noncash Financing Information:
Purchase of property and equipment included in accounts payable and accrued expenses
Exercise of cashless warrants
Deferred offering costs charged against proceeds from sale of common stock
Deferred offering costs accrued
Shares issues for vested restricted stock awards
Pay vs Performance Disclosure [Table]
Executive Category [Axis]
Individual [Axis]
Adjustment to Compensation [Axis]
Measure [Axis]
Pay vs Performance Disclosure, Table
Company Selected Measure Name
Named Executive Officers, Footnote
Peer Group Issuers, Footnote
Changed Peer Group, Footnote
PEO Total Compensation Amount
PEO Actually Paid Compensation Amount
Adjustment To PEO Compensation, Footnote
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Adjustment to Non-PEO NEO Compensation Footnote
Equity Valuation Assumption Difference, Footnote
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Company Selected Measure
Total Shareholder Return Vs Peer Group
Compensation Actually Paid vs. Other Measure
Tabular List, Table
Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Net Income (Loss)
Company Selected Measure Amount
Other Performance Measure, Amount
Adjustment to Compensation, Amount
PEO Name
Name
Non-GAAP Measure Description
Additional 402(v) Disclosure
Pension Benefits Adjustments, Footnote
Equity Awards Adjustments, Footnote
Erroneously Awarded Compensation Recovery [Table]
Restatement Determination Date [Axis]
Restatement Determination Date
Aggregate Erroneous Compensation Amount
Erroneous Compensation Analysis
Stock Price or TSR Estimation Method
Outstanding Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Not Yet Determined
Name
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery, Explanation of Impracticability
Name
Compensation Amount
Restatement does not require Recovery
Awards Close in Time to MNPI Disclosures [Table]
Award Timing MNPI Disclosure
Award Timing Method
Award Timing Predetermined
Award Timing MNPI Considered
Award Timing, How MNPI Considered
MNPI Disclosure Timed for Compensation Value
Awards Close in Time to MNPI Disclosures, Table
Name
Underlying Securities
Exercise Price
Fair Value as of Grant Date
Underlying Security Market Price Change
Insider Trading Arrangements [Line Items]
Material Terms of Trading Arrangement
Name
Title
Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted
Adoption Date
Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated
Termination Date
Expiration Date
Arrangement Duration
Aggregate Available
Insider Trading Policies and Procedures [Line Items]
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Not Adopted
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of Business
Accounting Policies [Abstract]
Summary of Significant Accounting Policies
Prepaid Expenses And Other Current Assets
Prepaid Expenses and Other Current Assets
Payables and Accruals [Abstract]
Accounts Payable and Accrued Expenses
Property, Plant, and Equipment [Abstract]
Property and Equipment
Equity [Abstract]
Stockholders’ Equity
Licenses Acquired
Licenses Acquired
Cirm Grants
CIRM Grants
Leases
Leases
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies
Related Party Transactions [Abstract]
Related Party Transactions
Subsequent Events [Abstract]
Subsequent Events
Basis of Presentation
Risk and Uncertainties
Use of Estimates in Financial Statement Presentation
Principles of Consolidation
Segment Reporting
Liquidity and Going Concern
Concentration of Credit Risk
Cash and Cash Equivalents
Short-term and Long-term Investments
Fair Value of Financial Instruments
Australian Tax Incentive
Deferred Offering Costs
Stock-Based Compensation
Research and Development Costs
Other Comprehensive Income (Loss)
Foreign Currency Translation and Transaction Gains (Losses)
Loss Per Common Share
Property and Equipment
Leases
Patent Costs
Advertising Costs
Grant Income
Emerging Growth Company Status
Recent Accounting Pronouncements
Schedule of Asset Measured at Fair Value on a Recurring Basis
Schedule of Property and Equipment Useful Lives
Schedule of Prepaid Expenses and Other Current Assets
Schedule of Accounts Payable and Accrued Expenses
Schedule of Property and Equipment
Accumulated Other Comprehensive Income (Loss) [Table]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Schedule of Stock Option Valuation Assumption
Schedule of Stock Option Activity
Schedule of Stock Outstanding and Exercisable
Schedule of Stock Warrant Activity
Schedule of Lease Cost for Operating Leases
Schedule of Lease Related Assets and Liabilities
Schedule of Maturity Lease Liability
Defined Benefit Plan [Table]
Defined Benefit Plan Disclosure [Line Items]
Total
Short-term investments (US Treasuries)
Long-term investments (US Treasuries)
Property, Plant, and Equipment [Table]
Property, Plant, and Equipment [Line Items]
Useful life
Non-controlling interest rate
Number of reportable segments
Number of operating segments
Net loss
Accumulated deficit
Grants receivable on reimbursement
Grants receivable
Grants receivable based on achievement of milestones
Shares issued value
Commission rate
Shares issued under ATM facility
Shares issued under ATM facility, value
Number of shares sold
Net proceeds of common stock
Issuance of shares
Issuance of warrants
Share price
Proceeds from private placement
Share price
Number of shares sold in public offering
Shares issued
Exercise price, per share
Cash and cash equivalents and short term invesrments
Cash and cash equivalents and long term invesrments
FDIC insured amount
Short-Term Investments
Research and development expense
Income taxes receivable
Deferred offering costs
Foreign currency transaction gains and losses
Underlying pre-funded warrants
Antidilutive securities excluded from computation of earnings per share, amount
Filer category description
Schedule Of Prepaid Expenses And Other Current Assets
Prepaid research and development expenses
Prepaid insurance expense
Other current assets
Total prepaid expenses and other current assets
Accounts payable
Accrued research and development expenses
Accrued professional services
Accrued compensation and related expenses
Other accrued expenses
Total accounts payable and accrued expenses
Total property and equipment, gross
Less: Accumulated depreciation
Property and Equipment, net
Depreciation expense
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Volatility, minimum
Volatility, maximum
Expected life (years)
Risk-free interest rate, minimum
Risk-free interest rate, maximum
Dividend rate
Options, Outstanding, Beginning
Weighted-Average Exercise Price Per Share, Outstanding, Beginning
Options, Granted
Weighted-Average Exercise Price Per Share, Granted
Options, Exercised
Weighted-Average Exercise Price Per Share, Exercised
Options, Forfeited
Weighted-Average Exercise Price Per Share, Forfeited
Options, Expired
Weighted-Average Exercise Price Per Share, Expired
Options, Outstanding, Ending
Weighted-Average Exercise Price Per Share, Outstanding, Ending
Outstanding, exercise price lower range limit
Outstanding, exercise price upper range limit
Outstanding, Number of Option Shares
Outstanding, Weighted Average Exercise Price
Outstanding, Weighted Average Remaining Life (Years)
Exercisable, Number of Option Shares
Exercisable, Weighted Average Exercise Price
Outstanding, Exercise Price
Warrants, Outstanding and exercisable, Beginning
Weighted-Average Exercise Price Per Share, Outstanding and exercisable Beginning
Warrants, Granted
Weighted-Average Exercise Price Per Share, Granted
Warrants, Exercised
Weighted-Average Exercise Price Per Share, Exercised
Warrants, Forfeited
Weighted-Average Exercise Price Per Share, Forfeited
Warrants, Expired
Weighted-Average Exercise Price Per Share, Expired
Warrants, Outstanding and exercisable, Ending
Weighted-Average Exercise Price Per Share, Outstanding and exercisable Ending
Proceeds from issuance initial public offering
Shares sold
Number of shares sold, value
Stock Issued During Period, Shares, Other
Class of Warrant or Right, Outstanding
Shares price per share
Proceeds from Issuance of Private Placement
Warrants term
Exercise price
Number of shares issued
Warrant issued
PreFunded warrant effect description
Number of shares issued
Number of shares issued, value
Number of shares issued upon exercise
Proceeds from stock options exercised
Number of exercise warrants, shares
Number of exercise warrants value
Stock-based compensation expense
Unrecognized stock-based compensation expense
Number of shares issued
Common stock number of shares to be issued
Total number of shares reserve
Share price percentage
Options granted to purchase common stock
Options term
Exercise price per share
Vesting period
Exercise price per share, lower range limit
Exercise price per share, upper range limit
Stock based compensation
Unrecognized stock-based compensation expense
Weighted-average vesting period
Intrinsic value option vested
Intrinsic value of warrants vested and outstanding
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Upfront license fee
Quarterly payments description
Royality payment percentage
Revenues
Upfront license fee
Development milestone payments
Installment due paymant
Net licensed
Milestone payments
Grants receivable
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Line Items]
Area of land
Payments for rent
Description of lease extensions
Incremental borrowing rate
Schedule Of Lease Cost For Operating Leases
Operating lease cost
Short-term lease cost
Total lease cost
Schedule Of Lease Related Assets And Liabilities
Operating Leases
Operating lease right-of-use assets
Right of use liability operating lease current portion
Right of use liability operating lease long term
Total operating lease liabilities
2026 (remaining 6 months)
2027
2028
2029
2030
2031 and thereafter
Total future undiscounted lease payments
Less: Interest
Present value of lease liabilities
Loss Contingencies [Table]
Loss Contingencies [Line Items]
Annual base salary
Performance bonuses percentage
Reimburesments and accured percentage
Related party expenses
Subsequent Event [Table]
Subsequent Event [Line Items]
June 2025 ATM Agreement [Member]
Securities Purchase Agreements [Member]
PreFunded warrant effect description.
Marketing Service Agreement [Member]
July 25, 2023 [Member]
Marketing Services Agreement [Member]
Common Stock Warrants [Member]
2016 Plan [Member]
2021 Plan [Member]
Amended and Restated 2021 Omnibus Equity Incentive Plan [Member]
Amended and Restated 2022 Omnibus Equity Incentive Plan [Member]
Share based compensation arrangement by share based payment award shares reserve.
Share price percentage.
Stock issued during period value shares issued for cashless exercise of warrants.
Stock issued during period shares shares issued for cashless exercise of warrants.
Shares issued under ATM facility for cash proceeds, net of offering costs shares.
Shares issued under ATM facility for cash proceeds, net of offering costs value.
Range One [Member]
Range Two [Member]
Range Three [Member]
Range Four [Member]
Range Five [Member]
Employees [Member]
Non-Employees [Member]
Management of the Company [Member]
Purchases of property and equipment included in accounts payable and accrued liabilities.
Exercise of cashless warrants.
Shares issues for vested restricted stock awards.
Granted.
Exercised.
Forfeitures.
Expiration.
Proceeds from sale of common stock under public offering, net of offering costs.
Deferred offering costs charged against proceeds from sale of common stock.
Deferred offering costs accrued.
Proceeds from stock warrants exercised.
Risk and Uncertainties [Policy Text Block]
Share based compensation shares authorized under stock option plans exercise price range.
Licenses Acquired [Text Block]
Upfront fee.
Royality payment percentage.
Upfront license fee.
Research and License Agreement [Member]
Development milestone payments.
License Agreement [Member]
Milestone payments.
Phase II Studies [Member]
Phase III Studies [Member]
Licensed Product [Member]
CIRM Grants Disclosure [Text Block]
Grants receivable based on achievement of milestones.
Lessee operating lease liability payments due year five and thereafter.
Performance bonuses percentage.
Employment Agreement [Member]
Dr. Rachman [Member]
Reimburesments and accured percentage.
Management Sevices Agreement [Member]
Mr. Morris [Member]
RobinhoodIIL [Member]
Immix Biopharma Australia Pty Ltd. [Member]
Liquidity and Going Concern [Policy Text Block]
Citizens ATM Agreement [Member]
2026 Underwriting Agreement [Member]
Exercise of warrants shares.
Exercise of warrants value.
Nexcella 2022 Equity Incentive Plan [Member]
Range Six [Member]
Commission rate.
PreFunded Warrant [Member]
Short Term and Long Term Investments [Policy Text Block]
Australian Tax Incentive [Policy Text Block]
Australian Tax Incentive [Member]
Prefunded Warrants [Member]
Stock Options and Warrants Exercisable [Member]
Stock Options and Warrants Exercisable One [Member]
Property Plant And Equipment Estimated Useful Lives [TextBlock]
Operating Equipment [Member]
Electronic Equipment [Member]
Grant Income [Policy Text Block]
Emerging Growth Company Status [Policy Text Block]
Prepaid Expenses And Other Current Assets [Text Block]
Prepaid Expenses and Other Current Assets Table [Text Block]
Prepaid research and development expenses.
Accrued research and development expenses.
Accrued professional services.
Filer category description.
Underwritten Offering [Member]
Share based compensation arrangement by share based payment award non option equity weighted average exercise price
Stock issued during period value shares issued for cash exercise of warrants.
Stock issued during period shares issued for cash exercise of warrants.
Assets, Current
Assets
Liabilities, Current
Liabilities
Treasury Stock, Common, Value
Equity, Including Portion Attributable to Noncontrolling Interest
Liabilities and Equity
Operating Expenses
Operating Income (Loss)
Nonoperating Income (Expense)
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest
Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest
Equity, Attributable to Parent
Shares, Outstanding
Share-Based Payment Arrangement, Noncash Expense
Gain (Loss) on Disposition of Property Plant Equipment
Debt Securities, Available-for-Sale, Realized Gain
Increase (Decrease) in Income Taxes Receivable
Increase (Decrease) in Prepaid Expense and Other Assets
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Investments
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation
Forgone Recovery, Individual Name
Outstanding Recovery, Individual Name
Awards Close in Time to MNPI Disclosures, Individual Name
Trading Arrangement, Individual Name
Licenses Acquired [Text Block]
Lessee, Operating Leases [Text Block]
Property, Plant, and Equipment [Policy Text Block]
Lessee, Leases [Policy Text Block]
Share Price
Deferred Offering Costs [Default Label]
Property, Plant, and Equipment, Excluding Lessor Asset under Operating Lease, Accumulated Depreciation
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityWeightedAverageExercisePrice
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityWeightedAverageExercisePriceGranted
Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityWeightedAverageExercisePriceExercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityWeightedAverageExercisePriceForfeitures
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityWeightedAverageExercisePriceExpirations
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Upfront license fee [Default Label]
Lease, Cost
Lessee, Operating Lease, Liability, to be Paid
Lessee, Operating Lease, Liability, Undiscounted Excess Amount